Kadcyla ( T-DM1 ) an Amazing New Breast Cancer Drug

http://youtu.be/XuBgPpCwqrw Kadcyla (T-DM1) is a FDA approved breast cancer drug that targets cancer cells while leaving healthy cells alone. Visit http://oacancer.com/kadcyla_t-dm1/ for more information on this promising new drug. These videos are produced by Dr. Stephen J. Lemon of Oncology Associates to help provide useful cancer information to cancer patients and survivors. Oncology Associates provides a full-range of personalized cancer treatment at two Omaha clinics, as well as at cancer treatment clinics throughout Nebraska, which include Blair and Norfolk. The cancer physicians of Oncology Associates include: * Stephen J. Lemon, MD * Irina E. Popa, MD * Laxmi Narayana R. Buddharaju, MD To learn more about OA's approach to personalized cancer treatment as well as about the oncologists and staff, please visit http://www.oacancer.com